Jakaria Shawon

Jakaria Shawon

Auto-generated profile, based on publicly available information

Jakaria Shawon

Nutrition Research Division, International Centre for Diarrhoeal Disease Research

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
JSJakaria Shawon
Jakaria Shawon
ZAZakia Akter
Zakia Akter
MHMd. Munnaf Hossen
Md. Munnaf Hossen
YAYeasmin Akter
Yeasmin Akter
ASAbu Sayeed
Abu Sayeed
MKMd. Asaduzzaman Khan
Md. Asaduzzaman Khan
Background: SARS-CoV-2 is a coronavirus, of which infection causing COVID-19 was first reported in Wuhan, China at the end of 2019, and the outbreak became pandemic in February of 2020. Till now there is no effective drug or vaccine against this virus that can make complete cure; however, a number of drugs are in trials. Objectives: In this review, we have focused on an alternative therapeutic approach using natural products utilizing host anti-viral responses for resolving COVID-19 pathogenesis. Methods: We have searched databases like PubMed, Scopus, Web of Science and Google Scholar for articles related to natural products and viral diseases, with a specific focus on coronaviruses, as well as other RNA viruses and recent updates on COVID-19 pandemic, and collected articles and reviewed comprehensively. Results: Scientific studies clarified the viral pathogenesis that involved viral entrance into host cells, and antiviral response inside the cells, which can be effectively targeted by numerous natural compounds from different sources. Many of these compounds can potentially target viral genomic material or protein machinery. Natural products which were found effective against other coronaviruses, especially SARS-CoV or MERS-CoV (which emerged in 2002 and 2012, respectively) might be effective against SARS-CoV-2 due to their structural similarities; however, it needs time to establish the clinical success of these drugs. Conclusion: COVID-19 pandemic is a global emergency problem and urgent drug development is necessary. Natural products can be the biggest source of drugs, as they have been found effective in other coronaviruses previously; however, it needs time to establish these drugs for clinical application.

29 October 2025 in mSphere
Verified
Journal Article
Open access
AFAline C. Freitas
Aline C. Freitas
GLGrace Li
Grace Li
JSJakaria Shawon
Jakaria Shawon
HQHuma Qamar
Huma Qamar
LPLisa G. Pell
Lisa G. Pell
DRDaniel Roth
Daniel Roth
The early infant gut microbiota is generally dominated by bifidobacteria, but there is substantial variation at the (sub)species level. Patterns of postnatal Bifidobacterium subspecies colonization in low- or middle-income countries have not been widely studied. We used (sub)species-specific qPCR to quantify B. infantis ( n = 1132) , B. longum ( n = 364), and B. breve ( n = 399) in stool samples from infants (0–6 months of age) in urban Dhaka, Bangladesh. B. infantis absolute abundance started low at birth but increased in the first two months, whereas B. longum and B. breve abundances remained comparatively low. B. infantis emerged earlier in infants delivered by C-section, but by ~2 months of age, infants delivered by C-section or vaginally had similar B. infantis absolute abundances. Infant antibiotic exposure (ever vs. never), human milk feeding patterns (exclusive, predominant, and partial), and detection of maternal stool B. infantis were not associated with infant B. infantis . In settings where B. infantis is widespread, its patterns of postnatal colonization can be used to inform the design of targeted microbiota-modifying interventions in infancy. IMPORTANCE: Bifidobacteria are considered to be an important member of the early infant gut microbiota, but several factors may influence the timing of their emergence and overall abundance. Moreover, bifidobacteria abundance varies considerably between different species and subspecies, underscoring the importance of techniques that enable sub-speciation. B. longum subspecies infantis ( B. infantis ) is thought to have several health-promoting properties, and despite growing interest in the use of B. infantis to promote health (e.g., probiotics), relatively few studies have explored its natural patterns of colonization, particularly in low- and middle-income countries. By applying (sub)species-specific qPCR, we precisely tracked the timing of emergence, longitudinal abundance patterns, and ecological dynamics of B. infantis , B. longum , and B. breve in the postnatal period, which provided new insights to inform the design of targeted microbiota-modifying interventions in early infancy.

11 January 2024 in Microbiology Spectrum
Verified
Journal Article
Open access
JSJakaria Shawon
Jakaria Shawon
LPLisa G. Pell
Lisa G. Pell
MKMamun Kabir
Mamun Kabir
KEKara Evans
Kara Evans
MHMehedi Hasan
Mehedi Hasan
RHRashidul Haque
Rashidul Haque
Lactiplantibacillus plantarum ATCC 202195 has probiotic properties that may be beneficial in early infancy. Since the effects of probiotics are often strain and dose specific, tools are needed to identify and enumerate L. plantarum ATCC 202195 with high sensitivity and specificity. Herein, a probe-based real-time quantitative PCR (qPCR) assay was developed to detect and enumerate L. plantarum ATCC 202195. The probe sequence contained a single nucleotide polymorphism within gene FEE41_08190 that was unique to L. plantarum ATCC 202195 at the time of the assay’s design. The linear dynamic range of the assay spanned five orders of magnitude with an R 2 that did not deviate from linearity and an amplification efficiency that ranged from 97% to 110% across six independent plates. At 95% confidence, the limit of detection in the assay was estimated at roughly 15 cells. No amplification was observed for reactions containing gDNA from seven other Lactobacillus species. This is the first report of a qPCR assay that detects and quantifies L. plantarum ATCC 202195. The assay is intended to be used as a resource for future clinical trials and commercial manufacturing settings. IMPORTANCE: When administered for seven consecutive days shortly after birth, the probiotic bacterium Lactiplantibacillus plantarum ATCC 202195 plus fructooligosaccharide (FOS) was reported to reduce sepsis and lower respiratory tract infection events during early infancy in a randomized trial in India. Since probiotic effects are often strain specific, strain-level detection and quantification by routine molecular methods enables the monitoring of safety outcomes, such as probiotic-associated bacteremia, and allows for the quality of probiotic interventions to be assessed and monitored (i.e., verify strain identity and enumerate). Despite the potential clinical applications of L. plantarum ATCC 202195, an assay to detect and quantify this strain has not previously been described. Herein, we report the design of primer and probe sequences to detect L. plantarum ATCC 202195 and the development and optimization of a real-time PCR assay to detect and quantify the strain with high specificity and high sensitivity.

15 June 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ASAndrew P. Shepherd
Andrew P. Shepherd
KCKeith R. Carney
Keith R. Carney
MRMajid Rostami
Majid Rostami
JSJakaria Shawon
Jakaria Shawon
AEAndrew Elliott
Andrew Elliott
MMMichelle C. Mendoza
Michelle C. Mendoza
Cell migration is realized through the fast and persistent protrusion of a leading edge in the direction of movement. The actin and adhesion structures that build edge protrusions are integrated such that pro-migration signaling pathways must control both assemblies to induce protrusion. Understanding the contribution of adhesion regulation has been complicated by the inability to selectively assay the nascent adhesions that promote edge protrusion. Here, we dissect how the core RAS → RAF → MEK → ERK pathway’s control of nascent adhesions contributes to edge protrusion and cell migration by targeting an ERK FRET biosensor to adhesions and quantifying ERK’s spatial and temporal activity. We find that ERK is activated in the assembling, membrane-proximal region of nascent adhesions through adhesion scaffold paxillin, which interacts with the ERK activator MEK. Tracking nascent adhesion dynamics during cell migration showed that ERK promotes both nascent adhesion assembly and disassembly to create a population of nascent adhesions with short lifetimes. MEK inhibition is partially complemented by expression of a talin R8vvv mutant that increases the nascent adhesion population, demonstrating the significance of ERK’s adhesion regulation for edge protrusion and migration persistence. These findings suggest that when new adhesions initiate, the ERK activation level dictates adhesion assembly and disassembly rates to specifically build nascent adhesions that rapidly turn over, an adhesion population that promotes protrusion persistence and migration.

6 March 2025 in medRxiv
Verified
Preprint
Open access
PDF file
AFAline C. Freitas
Aline C. Freitas
GLGrace Li
Grace Li
JSJakaria Shawon
Jakaria Shawon
HQHuma Qamar
Huma Qamar
LPLisa G. Pell
Lisa G. Pell
DRDaniel Roth
Daniel Roth
The early infant gut microbiota is dominated by bifidobacteria, but there is substantial variation at the (sub)species level. Patterns of postnatal Bifidobacterium subspecies colonization in low or middle-income countries have not been widely studied. We used (sub)species-specific qPCR to quantify B. infantis, B. longum , and B. breve in stool samples from 1132 infants (0-6 months) in urban Dhaka, Bangladesh. B. infantis absolute abundance started low but increased in the first two months, whereas B. longum and B. breve abundances remained comparatively low. B. infantis emerged earlier in infants delivered by C-section, but by ∼2 months of age, infants delivered by C-section or vaginally had similar B. infantis abundances. Infant antibiotic exposure, feeding patterns, and maternal stool B. infantis were not associated with infant B. infantis . In settings where B. infantis is widespread, its patterns of postnatal colonization can be used to inform the design of targeted microbiota-modifying interventions in infancy.